Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014

SMi ADMET 2014

30 Jun 2014 - 01 Jul 2014 - London, UK

Bookmark and Share

SMi presents the 9th annual conference on: ADMET

Enhancing drug quality by ADMET optimisation in discovery

SMi’s established ADMET conference has been a premier event in its field for almost a decade. The 9th annual event taking place on 30th June and 1st July in central London, will bring together even more industry leading experts to deliver over eighteen case study driven presentations. A focal point for anyone working in the market for drug discovery and development, attending provides a unique forum to engage with KOL’s and experts active in the field.

ADMET 2014 will enable delegates to gain valuable insights into enhancing drug quality by ADMET optimisation in discovery. It will focus on themes including Predictive ADME, Screening Approaches, Predictive Toxicology, Drug to Drug interactions and emerging issues such as regulatory changes. Click here for the agenda  

 Previous events in the ADMET series have received positive feedback from the industry including, 

"Excellent" – Pharmidex, "Nice mix of attendees" – Grunenthal, "Good conference at general level to update your current knowledge" - Orion Corporation and "Great conference…well organised" - Sanofi

Key Speakers Include:

  • Natalie Gobeau, Metabolism and Pharmacokinetics, Novartis
  • Dietmar-Weitz, Lab Head/ADME In Vitro Systems, Sanofi-Aventis
  • Sarah Baldwin, In Vitro DMPK Manager, GSK
  • Chris Powell, VP Safety Assessment, GSK
  • Georg Schmitt, Head of Toxicology, Roche Pharmaceuticals
  • Richard Thompson, Principal Scientist, AstraZeneca
  • Franck Atienzar, Associate Director, In Vitro and In Silico Toxicology, UCB
  • Adina Tocoian, Senior Clinical Pharmacologist, UCB
  • David Fairman, Senior Clinical Pharmacokinetist, MedImmune

Reasons to Attend:

  • Understand how to integrate ADME and toxicity data to enhance the prediction and understanding of drug safety in humans 
  • Hear the latest updates on drug transporters including the evolving transporter strategies in drug development and the different roles of drug transporters in R&D 
  • Explore the ADME properties of peptides in drug discovery 
  • Evaluate and overcome the challenges of making an accurate human dose prediction 

Registration is now live. Click here to secure your place today and save £300.

For further details and to book your place, visit:

Alternatively contact the Team on +44 (0)20 7827 6000 or email 

Further information
Scientific News
Researchers Develop Classification Model for Cancers Caused by KRAS
Most frequently mutated cancer gene help oncologists choose more effective cancer therapies.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Chromosomal Chaos
Penn study forms basis for future precision medicine approaches for Sezary syndrome
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Key to Natural Detoxifier’s Reactivity Discovered
Results have implications for health, drug design and chemical synthesis.
New Treatment for Obesity Developed
Researchers at the University of Liverpool, working with a global healthcare company, have helped develop a new treatment for obesity.
New Protein Found in Immune Cells
Immunobiologists from the University of Freiburg discover Kidins220/ARMS in B cells and demonstrate its functions.
Will Brain Palpation Soon Be Possible?
Researchers have developed non-invasive brain imaging technique which provides the same information as physical palpation.
Shaking Up the Foundations of Epigenetics
Researchers at the Centre for Genomic Regulation (CRG) and the University of Barcelona (UB) published a study that challenges some of the current beliefs about epigenetics.
Groundbreaking Computer Program Diagnoses Cancer in Two Days
Researchers have combined genetics with computer science and created a new diagnostic technology can with 85 per cent certainty identify the source of the disease and thus target treatment and, ultimately, improve the prognosis for the patient.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos